Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (31-40 of 236) with videos related to

Pageof 24
Sort By:
Oncology and Therapy|June 15, 2024
Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not KnowYang Zhou, Yu-Lun Chen, Xi-Yi Huang, et al.
Journal of Hematology & Oncology|April 14, 2016
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Ying-Jun Chang, Leo Luznik, Ephraim J Fuchs, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2009
[Determination of optimal time to second allogeneic peripheral blood stem cell harvest from healthy donors]Ying-jun Chang, Ming-rui Huo, Xiang-yu Zhao, et al.
Annals of Hematology|July 27, 2011
Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trialsYing-Jun Chang, Cui-Lian Weng, Li-Xia Sun, et al.
Expert Review of Anticancer Therapy|May 28, 2020
Measurable residual disease of acute lymphoblastic leukemia in allograft settings: how to evaluate and interveneYu-Qian Sun, Si-Qi Li, Xiao-Su Zhao, et al.
Access Microbiology|October 16, 2020
Antiviral activity of betacyanins from red pitahaya (<i>Hylocereus polyrhizus</i>) and red spinach (<i>Amaranthus dubius</i>) against dengue virus type 2 (GenBank accession no. MH488959)Ying Jun Chang, Lian Yih Pong, Sharifah S Hassan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 25, 2009
[Peripheral monocyte counts at first collection of allo-grafts predicts amount of CD34(+) cells in mixture of rhG-CSF primed bone marrow and mobilized peripheral stem cell grafts]Ying-Jun Chang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Transplant Immunology|May 27, 2009
Expression profiles of adhesion molecules on naïve T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factorYing-Jun Chang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Journal of Clinical Immunology|May 23, 2009
Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantationYing-Jun Chang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Expert Review of Hematology|November 18, 2023
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome themSi-Qi Li, Man Chen, Xi-Yi Huang, et al.
Pageof 24

Showing results (31-40 of 236) with videos related to

Sort By:
Pageof 24
Oncology and Therapy|June 15, 2024
Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not KnowYang Zhou, Yu-Lun Chen, Xi-Yi Huang, et al.
Journal of Hematology & Oncology|April 14, 2016
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Ying-Jun Chang, Leo Luznik, Ephraim J Fuchs, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2009
[Determination of optimal time to second allogeneic peripheral blood stem cell harvest from healthy donors]Ying-jun Chang, Ming-rui Huo, Xiang-yu Zhao, et al.
Annals of Hematology|July 27, 2011
Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trialsYing-Jun Chang, Cui-Lian Weng, Li-Xia Sun, et al.
Expert Review of Anticancer Therapy|May 28, 2020
Measurable residual disease of acute lymphoblastic leukemia in allograft settings: how to evaluate and interveneYu-Qian Sun, Si-Qi Li, Xiao-Su Zhao, et al.
Access Microbiology|October 16, 2020
Antiviral activity of betacyanins from red pitahaya (<i>Hylocereus polyrhizus</i>) and red spinach (<i>Amaranthus dubius</i>) against dengue virus type 2 (GenBank accession no. MH488959)Ying Jun Chang, Lian Yih Pong, Sharifah S Hassan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 25, 2009
[Peripheral monocyte counts at first collection of allo-grafts predicts amount of CD34(+) cells in mixture of rhG-CSF primed bone marrow and mobilized peripheral stem cell grafts]Ying-Jun Chang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Transplant Immunology|May 27, 2009
Expression profiles of adhesion molecules on naïve T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factorYing-Jun Chang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Journal of Clinical Immunology|May 23, 2009
Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantationYing-Jun Chang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Expert Review of Hematology|November 18, 2023
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome themSi-Qi Li, Man Chen, Xi-Yi Huang, et al.
Pageof 24